Alliancebernstein L.P. trimmed its position in Express Scripts Holding (NASDAQ:ESRX) by 3.9% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 999,112 shares of the company’s stock after selling 40,228 shares during the period. Alliancebernstein L.P.’s holdings in Express Scripts were worth $74,574,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. Raymond James Financial Services Advisors Inc. grew its holdings in shares of Express Scripts by 15.2% during the 3rd quarter. Raymond James Financial Services Advisors Inc. now owns 252,263 shares of the company’s stock worth $15,973,000 after purchasing an additional 33,269 shares in the last quarter. Victory Capital Management Inc. grew its holdings in shares of Express Scripts by 12.5% during the 3rd quarter. Victory Capital Management Inc. now owns 35,421 shares of the company’s stock worth $2,243,000 after purchasing an additional 3,940 shares in the last quarter. Boston Partners grew its holdings in shares of Express Scripts by 8.0% during the 3rd quarter. Boston Partners now owns 837,454 shares of the company’s stock worth $53,028,000 after purchasing an additional 62,359 shares in the last quarter. Global X MANAGEMENT CO LLC grew its holdings in shares of Express Scripts by 11.3% during the 3rd quarter. Global X MANAGEMENT CO LLC now owns 12,102 shares of the company’s stock worth $766,000 after purchasing an additional 1,227 shares in the last quarter. Finally, FDx Advisors Inc. grew its holdings in shares of Express Scripts by 12.5% during the 3rd quarter. FDx Advisors Inc. now owns 29,264 shares of the company’s stock worth $1,853,000 after purchasing an additional 3,255 shares in the last quarter. 87.70% of the stock is currently owned by hedge funds and other institutional investors.

How to Become a New Pot Stock Millionaire

Express Scripts Holding (NASDAQ ESRX) opened at $80.75 on Monday. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.67 and a quick ratio of 0.55. The company has a market capitalization of $45,320.00, a PE ratio of 10.43, a price-to-earnings-growth ratio of 0.99 and a beta of 0.94. Express Scripts Holding has a 1 year low of $55.80 and a 1 year high of $85.07.

Express Scripts (NASDAQ:ESRX) last posted its earnings results on Tuesday, February 27th. The company reported $2.16 EPS for the quarter, beating the consensus estimate of $2.09 by $0.07. The firm had revenue of $25.38 billion during the quarter, compared to the consensus estimate of $25.07 billion. Express Scripts had a return on equity of 25.19% and a net margin of 4.51%. The business’s quarterly revenue was up 2.1% on a year-over-year basis. During the same period last year, the company earned $1.88 earnings per share. equities research analysts anticipate that Express Scripts Holding will post 9.35 EPS for the current fiscal year.

Express Scripts declared that its board has approved a stock repurchase plan on Monday, December 18th that permits the company to repurchase 45,000,000 shares. This repurchase authorization permits the company to repurchase shares of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s management believes its shares are undervalued.

Several analysts have recently issued reports on ESRX shares. Robert W. Baird raised Express Scripts from a “neutral” rating to an “outperform” rating and increased their target price for the stock from $72.00 to $81.00 in a report on Friday, December 15th. Maxim Group lowered Express Scripts from a “buy” rating to a “hold” rating in a report on Thursday. Zacks Investment Research raised Express Scripts from a “hold” rating to a “buy” rating and set a $82.00 target price on the stock in a report on Wednesday, February 14th. Barclays initiated coverage on Express Scripts in a research note on Thursday. They issued an “equal weight” rating and a $84.00 price objective on the stock. Finally, Jefferies Group set a $80.00 price objective on Express Scripts and gave the company a “buy” rating in a research note on Friday, December 15th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and eight have given a buy rating to the company. The company has an average rating of “Hold” and an average target price of $81.97.

In other Express Scripts news, VP Glen D. Stettin sold 3,449 shares of the stock in a transaction dated Thursday, January 11th. The stock was sold at an average price of $81.00, for a total value of $279,369.00. Following the completion of the transaction, the vice president now directly owns 33,715 shares in the company, valued at $2,730,915. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Christine Houston sold 10,104 shares of the stock in a transaction dated Friday, December 15th. The shares were sold at an average price of $70.08, for a total value of $708,088.32. Following the completion of the transaction, the vice president now owns 87,400 shares of the company’s stock, valued at $6,124,992. The disclosure for this sale can be found here. Insiders sold 21,896 shares of company stock valued at $1,617,903 over the last quarter. Corporate insiders own 0.68% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Alliancebernstein L.P. Decreases Holdings in Express Scripts Holding (ESRX)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.thecerbatgem.com/2018/03/12/alliancebernstein-l-p-decreases-holdings-in-express-scripts-holding-esrx.html.

Express Scripts Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts and related companies with MarketBeat.com's FREE daily email newsletter.